A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.

“Emphysema makes it hard to breathe air out of your lungs as it affects the tiny air sacs at the end of the airways where ...

About Fexlamose Fexlamose is being developed as a chronic treatment for ... for mucus plugs in COPD and other muco-obstructive lung diseases has been slowed by a lack of predictive and monitoring ...

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

ACBT: Active cycle of breathing technique; ACTs: Airway clearance techniques; AD: Autogenic drainage; AECOPD: Acute exacerbation of chronic obstructive pulmonary disease; COPD: Chronic obstructive ...

Asthma–chronic obstructive pulmonary disease ... ACOS accounts for approximately 15–25% of the obstructive airway diseases and patients experience worse outcomes compared with asthma or ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

Fexlamose is being developed as a chronic treatment for COPD ... for mucus plugs in COPD and other muco-obstructive lung diseases has been slowed by a lack of predictive and monitoring biomarkers for ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

Many people’s symptoms worsen during the winter period. “We call this an exacerbation or a flare up, when you get ...

Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...